Author:
Wasan Kishor M.,Risovic Verica,Sivak Olena,Lee Stephen D.,Mason Douglas X.,Chiklis Gregory R.,McShane Jim,Lynn Melvyn,Wong Nancy,Rossignol Daniel P.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference24 articles.
1. X. Du, A. Poltorak, M. Silva, and B. Beutler. Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor. Blood Cells Mol. Dis. 25:328–338 (1999).
2. S. K. Huang, K. D. Lee, K. Hong, D. S. Friend, and D. Papahadjopoulos Microscopic localization of sterically stabilized liposomes in colon-carcinoma-bearing mice. Cancer Res. 52:5135–5143 (1992).
3. K. Kaneko, R. Ueda, K. Kikuchi, Y. Sano, and T. Yoshimura. Quantitative determination of a potent lipopolysaccharide antagonist, E5564, in rat and dog plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 736:67–75 (1999).
4. M. Lynn, D. P. Rossignol, J. L. Wheeler, R. J. Kao, C. A. Perdomo, R. Noveck, R. Vargas, T. D’Angelo, S. Gotzkowsky, and F. G. McMahon. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J. Infect. Dis. 187:631–639 (2003).
5. M. Mullarkey, J. R. Rose, J. Bristol, T. Kawata, A. Kimura, S. Kobayashi, M. Przetak, J. Chow, F. Gusovsky, W. J. Christ, and D. P. Rossignol. Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 304:1093–1102 (2003).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献